Validated antibody with 26 RRID-verified research citations across 1 target.

Heintz Lab TRAP anti-GFP 19C8

Heintz Lab; Rockefeller UniversityCat# Htz-GFP-19C8
26citations
ApplicationsAsk supplier
ReactivityAsk supplier
HostMouse
ClonalityMonoclonal
Research Usage26citations
View RRID verification

More CD19 antibodies from other suppliers

Compared on specifications and validation. No paid placements.

CD19 (Ab-531) Antibody
CUSABIOCat# CSB-PA253616
Validated · ELISA, WB
Applications
ELISAWB
Reactivity
HumanMouse
HostRabbit
ClonalityPolyclonal
View datasheet on CUSABIO
CD19 (FMC63) Recombinant Monoclonal Antibody
CUSABIOCat# CSB-RA004888MA3HUClone: 1G9
Validated · FC
Applications
FC
Reactivity
Human
Host
ClonalityMonoclonal
View datasheet on CUSABIO
CD19 (FMC63) Recombinant Monoclonal Antibody
CUSABIOCat# CSB-RA004888MA5HUClone: 12E8
Validated · ELISA, FC
Applications
ELISAFC
Reactivity
Human
Host
ClonalityMonoclonal
View datasheet on CUSABIO
CD19 (Tafasitamab) Recombinant Monoclonal Antibody
CUSABIOCat# CSB-RA004888MA4HUClone: 12G5
Validated · FC
Applications
FC
Reactivity
Human
Host
ClonalityMonoclonal
View datasheet on CUSABIO
CD19 Antibody
CUSABIOCat# CSB-PA006159
Validated · WB, ELISA
Applications
WBELISA
Reactivity
Human
HostRabbit
ClonalityPolyclonal
View datasheet on CUSABIO
CD19 Antibody
CUSABIOCat# CSB-PA001431
Validated · WB, ELISA
Applications
WBELISA
Reactivity
HumanMouseMonkey
HostRabbit
ClonalityPolyclonal
View datasheet on CUSABIO
CD19 Monoclonal Antibody
CUSABIOCat# CSB-MA004888A0mClone: 8G11B7
Validated · ELISA, WB, IHC
Applications
ELISAWBIHCIFFC
Reactivity
Human
HostMouse
ClonalityMonoclonal
View datasheet on CUSABIO
CD19 Monoclonal Antibody
CUSABIOCat# CSB-MA004888A1mClone: 4C6G1
Validated · ELISA, WB, IHC
Applications
ELISAWBIHCFC
Reactivity
Human
HostMouse
ClonalityMonoclonal
View datasheet on CUSABIO

+ 39 more CD19 options from other suppliers.

Product verified through the Antibody Registry (RRID). Application and species data from supplier specifications and published research. No paid placements.